Overview

Original Research

INDONESIAN VACCINE DIPLOMACY TO THE INDO-PACIFIC: OPPORTUNITIES AND CHALLENGES

DEASY SILVYA SARI 1, AKIM 2, MAS HALIMAH 3, and ALI ZAHID 4.

Vol 18, No 06 ( 2023 )   |  DOI: 10.17605/OSF.IO/24WJS   |   Author Affiliation: Department of International Relations, Universitas Padjadjaran, Indonesia 1,2; Department of Public Policy, Universitas Padjadjaran, Indonesia 3; The Center for Strategic and International Studies, Universitas Padjadjaran, Indonesia 4.   |   Licensing: CC 4.0   |   Pg no: 580-594   |   Published on: 15-06-2023

Abstract

The Covid-19 vaccine is one way to prevent the spread of Covid-19. Indonesia has produced Indovac, a Covid-19 vaccine made by Biopharma, which has the opportunity to be distributed to countries in the Indo-Pacific Region. This article explains the opportunities and challenges of Indonesia's vaccine diplomacy during the Covid-19 pandemic to the Indo-Pacific region through Biopharma. By using a vaccine diplomacy approach and qualitative methods with System Dynamic analysis, this article concludes that (i) The opportunity for Indonesia's vaccine diplomacy to the Indo-Pacific is 44% and (ii) The simulation results for all parameters have the opportunity to increase Indonesia's progress in the Indo-Pacific except for the parameters of cooperation with exceptional actors’ vaccine. The challenges for Indonesia's Covid-19 vaccine diplomacy to the Indo-Pacific come from the United States, India, Japan, Australia and Singapore.

Keywords

Vaccine Diplomacy, Indo-Pacific, Indonesia, Biopharma